{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "4-Iodo-4-Deoxydoxorubicin",
  "nciThesaurus": {
    "casRegistry": "83997-75-5",
    "chebiId": "CHEBI:47897",
    "chemicalFormula": "",
    "definition": "An iodinated doxorubicin analogue with antiamyloid activity. 4'-Iodo-4'-deoxydoxorubicin (IDOX) binds with high affinity to five types of natural amyloid fibrils including immunoglobulin light chains, amyloid A, transthyretin (methionine-30 variant), beta-protein (Alzheimer), and beta2-microglobulin. This agent may inhibit fibril growth, increasing the solubility of amyloid tissue deposits and facilitating their clearance. IDOX has also been shown to insulin amyloid fibrillogenesis in vitro.",
    "fdaUniiCode": "65JH75I9JX",
    "identifier": "C971",
    "preferredName": "4'-Iodo-4'-Deoxydoxorubicin",
    "semanticType": "Antibiotic",
    "subclassOf": [],
    "synonyms": [
      "4'-Deoxy-4'-Iododoxorubicin",
      "4'-Iodo-4'-Deoxydoxorubicin",
      "IDOX",
      "IODODOXORUBICIN",
      "Iodo-Doxorubicin",
      "Iododoxorubicin",
      "iododoxorubicin"
    ]
  }
}